Skip to content

Cardiac Rehabilitation in Heart Disease Patient

The effect of a cardiac rehabilitation program on systolic, diastolic function, left ventricle mass and functional capacity in patient with myocardial infarction

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201011085136N1
Enrollment
30
Registered
2011-05-10
Start date
2010-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial Infarction. Myocardial Infarction specified as Acute or with a stated duration of 4 weeks (28 days) or less from onset

Interventions

Intervention 1: Rehabilitation program for 8-week course of aerobic exercise (three 60-minute sessions per week). Aerobic exercise including stretching exercises for warm-up, aerobic exercises on trea
Rehabilitation
Lifestyle
Rehabilitation program for 8-week course of aerobic exercise (three 60-minute sessions per week). Aerobic exercise including stretching exercises for warm-up, aerobic exercises on treadmill ergo meter
2 month detraining for control group

Sponsors

Isfahan Cardivascular Research Center
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
37 Years to 67 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients with ST elevation myocardial infarction, history of CABG and PTCA, have ability to present in cardiac rehabilitation program, not having any physical exercise out of cardiac rehabilitation program, cardiac rehabilitation start 2 month after CABG and 1 month after PTCA Exclusion criteria: Absence more than five sessions in rehabilitation programs, re-infarction, extra physical activity.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Left Ventricular End Diastolic Dimention. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiography.;Left Ventricular End Systolic Dimention. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.;Left Ventricular End Systolic Volume. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.;Left Ventricular End Diastolic Volume. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.;Ejection Fraction. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.;Stroke Volume. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: 2 Dimentional Echocardiograph.;E velocity. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.;A velocity. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.;E/A ratio. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.;Deceleration time. Timepoint: Before Intervention and 2 month After Intervention. Method of measurement: Pulsed Wave Doppler Echocardiography.

Secondary

MeasureTime frame
Left ventricle mass. Timepoint: Before Intervention and 2 Month After Intervention. Method of measurement: 2 Dimentional Echocardiography.;Blood Pressure. Timepoint: Before Intervention and 2 Month After Intervention. Method of measurement: Sphyngomanometer.;Functional Capacity. Timepoint: Before Intervention and 2 Month After Intervention. Method of measurement: Naghoutan Protocol.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Basati

Isfahan Univercity

basatifatemeh@yahoo.com: fatemeh.basati1987@gmail.com+98 83 2524 1887

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026